CD4 and Alzheimer disease: Previous research has demonstrated that patients with AD exhibit a significant reduction in CD8+ T cell subsets, a significant increase in CD4+ helper T cells, and a significant correlation between the CD4/CD8 ratio and cognitive decline that is characteristic of AD (Unger et al., 2020).